Pfizer (PFE.N)and partner BioNTech (22UAy.DE) plan to ask U.S. and European regulators within weeks to authorize a booster dose of its COVID-19 vaccine, based on evidence of greater risk of infection six months after inoculation and the spread of the highly contagious Delta variant. The U.S. Food and Drug Administration (FDA) and the Centers for Disease Control and...
Tag: BIONTECH
Post
Post
Pfizer Marathon kicks off in Akkar, Baalbek-Hermel, Bekaa
The Pfizer Vaccine Marathon, organized by the Ministry of Public Health, kicked off this morning for residents of Akkar, Baalbek-Hermel, and the Bekaa, where those aged over 60 will be able to receive a first dose of the Pfizer-BioNTech vaccine.
Post
Vaccine firms pledge 3.5 Bn Covid Doses for poorer nations
Pfizer, Moderna and Johnson & Johnson told a G20 health summit Friday they will supply around 3.5 billion Covid-19 vaccine doses at cost or discount to poorer nations this year and next. US pharma giant Pfizer will deliver two billion doses “over the next 18 months”, including one billion in 2021, chairman and chief executive...
Post
BioNTech co-founder says he’s confident that vaccine works against Indian variant
BioNTech co-founder Ugur Sahin voices confidence that the vaccine his company jointly developed with Pfizer works against the Indian variant of the coronavirus. “We are still testing the Indian variant, but the Indian variant has mutations that we have already tested for and which our vaccine works against, so I am confident,” says Sahin. “The...
Post
France to mix vaccine doses in response to concerns over AstraZeneca jab
France will give the Pfizer/BioNTech or Moderna vaccine as a second dose to people aged under 55 who have already received a first dose of the Oxford/AstraZeneca jab, as part of its response to concerns about rare blood clotting incidents. The decision was announced on Friday after a recommendation from the Haute Autorité de Santé,...
Post
Biotech aims for 2 billion COVID-19 vaccine doses in 2021
German COVID-19 vaccine maker Biotech, partner of U.S. pharmaceutical group Pfizer , said on Monday it aims to produce two billion doses of its vaccine this year. “We now believe that we can potentially deliver approximately 2 billion doses in total by the end of 2021, which incorporates the updated 6-dose label,” Biotech said in...